Q3 2025 net product revenue increased 223% year-over-year to $438 thousandGross profit/(loss) decreased from $24 thousand to $(100) ...
Following publication of KEYNOTE-689 Phase 3 results confirming the role of perioperative checkpoint inhibition in head and neck cancer, GeoVax announced plans for a Phase 2 trial (AdPNP-203) ...
Odyssey Math Tuition launches JC 1 H2 Math online tuition elearning course in Singapore, featuring a proprietary MOE-aligned ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback